Back to products
Tirzepatide
Research only
In stock — ships from Australia
$118.99
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for potent metabolic effects. It promotes appetite suppression, insulin sensitivity and significant fat-mass reduction in research models, typically outperforming single-agonist comparators.Purity: ≥99% (RP-HPLC, CoA per batch). Lyophilised powder, shipped from Australian stock.For laboratory research use only. Not for human consumption.
Add 4 more vials to unlock $98.99 per vial.
Volume pricing — 10mg
| Quantity | Per vial | Save |
|---|---|---|
| 1-4 vials | $118.99 | — |
| 5+ vials | $98.99 | 17% |
| 10+ vials | $80.99 | 32% |
| 20+ vials | $59.99 | 50% |
Certificate of Analysis & lab testing
Batch-specific certificates of analysis for Tirzepatide are issued per lot. Request the current COA and third-party lab report and we'll email the PDFs to you.
Request COAResearch use only
This product is sold strictly for laboratory research purposes. Not for human consumption, diagnostic, or therapeutic use.